(Q43041106)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17911459%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

title

Impact of steroids on hepatitis C virus replication in vivo and in vitro (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17911459%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

1 reference

1 reference

Luc J.W. van der Laan

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17911459%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

author name string

Scot D Henry

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17911459%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Herold J Metselaar

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17911459%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Jeroen Van Dijck

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17911459%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Hugo W Tilanus

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17911459%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

language of work or name

English

0 references

publication date

1 September 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17911459%20AND%20SRC:MED&resulttype=core&format=json

Annals of the New York Academy of Sciences

8 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17911459%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

volume

1110

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17911459%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

page(s)

439-447

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17911459%20AND%20SRC:MED&resulttype=core&format=json

Impact of immunosuppressive therapy on recurrence of hepatitis C.

8 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1423.046

Interferon and prednisone therapy in chronic hepatitis C with non-organ-specific antibodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1423.046

Hepatitis C viremia in chronic liver disease: relationship to interferon-alpha or corticosteroid treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1423.046

A longitudinal analysis of hepatitis C virus replication following liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1423.046

Long-term outcome of hepatitis C infection after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1423.046

Viral dynamics of hepatitis C early after orthotopic liver transplantation: evidence for rapid turnover of serum virions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1423.046

Association of multispecific CD4(+) response to hepatitis C and severity of recurrence after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1423.046

The role of different immunosuppression in the long-term histological outcome of HCV reinfection after liver transplantation for HCV cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1423.046

Double-blind comparison of hepatitis C histological recurrence Rate in HCV+ Liver transplant recipients given basiliximab + steroids or basiliximab + placebo, in addition to cyclosporine and azathioprine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1423.046

Immunosuppression without steroids in liver transplantation is safe and reduces infection and metabolic complications: results from a prospective multicenter randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1423.046

Management of hepatitis C in liver transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1423.046

Significant improvement in the outcome of HCV-infected transplant recipients by avoiding rapid steroid tapering and potent induction immunosuppression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1423.046

Slowly tapering off steroids protects the graft against hepatitis C recurrence after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1423.046

The role of immunosuppression in recurrence of hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1423.046

Immunosuppression for liver transplantation in HCV-infected patients: mechanism-based principles

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1423.046

Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1423.046

Mycophenolic acid inhibits hepatitis C virus replication and acts in synergy with cyclosporin A and interferon-alpha.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1423.046

Simultaneous targeting of HCV replication and viral binding with a single lentiviral vector containing multiple RNA interference expression cassettes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1423.046

Dissecting the interferon-induced inhibition of hepatitis C virus replication by using a novel host cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1423.046

Physical association and functional antagonism between the p65 subunit of transcription factor NF-kappa B and the glucocorticoid receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1423.046

Nuclear integration of glucocorticoid receptor and nuclear factor-kappaB signaling by CREB-binding protein and steroid receptor coactivator-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1423.046

The glucocorticoid receptor inhibits NFkappaB by interfering with serine-2 phosphorylation of the RNA polymerase II carboxy-terminal domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1423.046